English
Aarti Pharmalabs Q2 Results
- BSE: 543748
- NSE: AARTIPHARM
- ISIN: INE0LRU01027
- Sector: Biotechnology & Drugs
BSE
768.15
7.80 (1.03%)
7.80 (1.03%)Volume99.70 K
Updated: Fri 23 Jan, 2026 | 15:25:50
NSE
770.059.90 (1.30%)
9.90 (1.30%)Volume2.23 L
Updated: Fri 23 Jan, 2026 | 15:25:51
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹418.33 Cr.(-8.67%)
- Operating Profit₹49.95 Cr.(-31.38%)
- Profit After Tax₹27.92 Cr.(-48.88%)
- Operating Margin11.94%(-24.87%)
Note: Comparison is on YoY basis
Quarterly - Aarti Pharmalabs Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 368.39 | 313.74 | 17.42% | 385.24 | -4.37% |
| Depreciation/ Amortization | 24.77 | 22.79 | 8.67% | 20.88 | 18.61% |
| Operating Income | 49.95 | 72.45 | -31.06% | 72.79 | -31.38% |
| Net Income | 27.92 | 49.50 | -43.59% | 54.62 | -48.88% |
| Other Operating Expenses Total | 90.43 | 80.29 | 12.63% | 91.05 | -0.68% |
| Net Income Before Taxes | 38.69 | 65.45 | -40.89% | 71.77 | -46.09% |
| Total Revenue | 418.33 | 386.19 | 8.32% | 458.03 | -8.67% |
| Selling/ General/ Admin Expenses Total | 43.41 | 41.26 | 5.22% | 37.73 | 15.06% |
| Diluted Normalized EPS | 3.08 | 5.46 | -43.59% | 6.02 | -48.84% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.